|
24 Jan 2020 |
Genentech Provides an Update on Phase III Study of Tecentriq in People With Muscle-Invasive Urothelial Cancer
|
|
24 Jan 2020 |
Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma
|
|
23 Jan 2020 |
Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal Cancer
|
|
23 Jan 2020 |
iOnctura Raises EUR 15 Million in Series A Financing to Progress its Pipeline into Clinical Development
|
|
23 Jan 2020 |
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
|
|
23 Jan 2020 |
Cadent Therapeutics Announces FDA Acceptance of IND Application for CAD-1883 for Spinocerebellar Ataxia (SCA)
|
|
23 Jan 2020 |
BlackThorn Therapeutics Advances Phase 2 Clinical Development for Selective KOR Antagonist, BTRX-140, in Neuropsychiatric Disorders
|
|
23 Jan 2020 |
Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
|
|
23 Jan 2020 |
The European Commission Approves Expanded Use of Janssen’s STELARA® (ustekinumab) for the Treatment of Paediatric Patients With Moderate to Severe Plaque Psoriasis
|
|
23 Jan 2020 |
Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody
|
|
23 Jan 2020 |
Biohaven's Verdiperstat Receives FDA May Proceed Letter To Initiate Trial In Amyotrophic Lateral Sclerosis Conducted By The Healey Center For ALS At Mass General
|
|
23 Jan 2020 |
Genentech’s Risdiplam Meets Primary Endpoint in Pivotal FIREFISH Trial in Infants With Type 1 Spinal Muscular Atrophy
|
|
22 Jan 2020 |
Kintai Therapeutics Advances Anti-Obesity Agent KTX-0200 into IND-Enabling Studies Following Positive Preclinical Data Demonstrating Sustained Weight Loss and Improved Health Markers
|
|
22 Jan 2020 |
INHIBITOR Therapeutics Receives prostate cancer IND Clearance from FDA
|
|
22 Jan 2020 |
Metacrine Demonstrates Best-in-Class FXR Drug Program with Positive Clinical Results in NASH Patients
|
|
22 Jan 2020 |
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx
|
|
22 Jan 2020 |
Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy
|
|
22 Jan 2020 |
LB Pharmaceuticals Announces the Initiation of Patient Dosing in a First-in-Human Phase 1 Study of LB-102, a Novel Benzamide for the Treatment of Schizophrenia
|
|
22 Jan 2020 |
Celularity Announces FDA Clearance of Landmark IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy
|
|
22 Jan 2020 |
Ocuphire Pharma Announces In-License of Phase 2 Oral Small Molecule Drug Candidate for Diabetic Retinopathy and Diabetic Macular Edema from Apexian Pharmaceuticals
|
